Global Contraceptive Drug Eluting Devices Market by Size, by Type, by Application, by Region, History and Forecast 2020-2031

Summary

According to APO Research, The global Contraceptive Drug Eluting Devices market is projected to grow from US$ million in 2025 to US$ million by 2031, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The US & Canada market for Contraceptive Drug Eluting Devices is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

Asia-Pacific market for Contraceptive Drug Eluting Devices is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

The China market for Contraceptive Drug Eluting Devices is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

Europe market for Contraceptive Drug Eluting Devices is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

The major global manufacturers of Contraceptive Drug Eluting Devices include CooperSurgical, Egemen International, ERENLER MEDIKAL, Gyneas, Laboratoire CCD, Medical Engineering Corporation, Melbea, Meril Life Sciences and Mona Lisa, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.

This report presents an overview of global market for Contraceptive Drug Eluting Devices, sales, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2020-2024, estimates for 2025, and projections of CAGR through 2031.

This report researches the key producers of Contraceptive Drug Eluting Devices, also provides the sales of main regions and countries. Of the upcoming market potential for Contraceptive Drug Eluting Devices, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Contraceptive Drug Eluting Devices sales, revenue, market share and industry ranking of main manufacturers, data from 2020 to 2025. Identification of the major stakeholders in the global Contraceptive Drug Eluting Devices market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2020 to 2031. Evaluation and forecast the market size for Contraceptive Drug Eluting Devices sales, projected growth trends, production technology, application and end-user industry.

Contraceptive Drug Eluting Devices Segment by Company

CooperSurgical
Egemen International
ERENLER MEDIKAL
Gyneas
Laboratoire CCD
Medical Engineering Corporation
Melbea
Meril Life Sciences
Mona Lisa
Pregna
Pregna International
Prosan International
Rongbo Medical
SMB Corporation of India
AbbVie
Bayer
Contraceptive Drug Eluting Devices Segment by Type

Non-biodegradable
Biodegradable
Contraceptive Drug Eluting Devices Segment by Application

Subcutaneously
Uterus
Contraceptive Drug Eluting Devices Segment by Region

North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.
2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Contraceptive Drug Eluting Devices market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Contraceptive Drug Eluting Devices and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Contraceptive Drug Eluting Devices.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Contraceptive Drug Eluting Devices market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2020-2031).
Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Contraceptive Drug Eluting Devices manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Contraceptive Drug Eluting Devices in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Revenue of Contraceptive Drug Eluting Devices in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.
Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Concluding Insights of the report

Please Note: Single-User license will be delivered via PDF from the publisher without the rights to print or to edit.


1 Market Overview
1.1 Product Definition
1.2 Global Contraceptive Drug Eluting Devices Market Size, 2020 VS 2024 VS 2031
1.3 Global Contraceptive Drug Eluting Devices Market Size Estimates and Forecasts (2020-2031)
1.4 Global Contraceptive Drug Eluting Devices Sales Estimates and Forecasts (2020-2031)
1.5 Global Contraceptive Drug Eluting Devices Market Average Price (2020-2031)
1.6 Assumptions and Limitations
1.7 Study Goals and Objectives
2 Global Contraceptive Drug Eluting Devices Market Dynamics
2.1 Contraceptive Drug Eluting Devices Industry Trends
2.2 Contraceptive Drug Eluting Devices Industry Drivers
2.3 Contraceptive Drug Eluting Devices Industry Opportunities and Challenges
2.4 Contraceptive Drug Eluting Devices Industry Restraints
3 Contraceptive Drug Eluting Devices Market by Manufacturers
3.1 Global Contraceptive Drug Eluting Devices Revenue by Manufacturers (2020-2025)
3.2 Global Contraceptive Drug Eluting Devices Sales by Manufacturers (2020-2025)
3.3 Global Contraceptive Drug Eluting Devices Average Sales Price by Manufacturers (2020-2025)
3.4 Global Contraceptive Drug Eluting Devices Industry Manufacturers Ranking, 2023 VS 2024 VS 2025
3.5 Global Contraceptive Drug Eluting Devices Key Manufacturers Manufacturing Sites & Headquarters
3.6 Global Contraceptive Drug Eluting Devices Manufacturers, Product Type & Application
3.7 Global Contraceptive Drug Eluting Devices Manufacturers Establishment Date
3.8 Market Competitive Analysis
3.8.1 Global Contraceptive Drug Eluting Devices Market CR5 and HHI
3.8.2 Global Top 5 and 10 Contraceptive Drug Eluting Devices Players Market Share by Revenue in 2024
3.8.3 2024 Contraceptive Drug Eluting Devices Tier 1, Tier 2, and Tier 3
4 Contraceptive Drug Eluting Devices Market by Type
4.1 Contraceptive Drug Eluting Devices Type Introduction
4.1.1 Non-biodegradable
4.1.2 Biodegradable
4.2 Global Contraceptive Drug Eluting Devices Sales by Type
4.2.1 Global Contraceptive Drug Eluting Devices Sales by Type (2020 VS 2024 VS 2031)
4.2.2 Global Contraceptive Drug Eluting Devices Sales by Type (2020-2031)
4.2.3 Global Contraceptive Drug Eluting Devices Sales Market Share by Type (2020-2031)
4.3 Global Contraceptive Drug Eluting Devices Revenue by Type
4.3.1 Global Contraceptive Drug Eluting Devices Revenue by Type (2020 VS 2024 VS 2031)
4.3.2 Global Contraceptive Drug Eluting Devices Revenue by Type (2020-2031)
4.3.3 Global Contraceptive Drug Eluting Devices Revenue Market Share by Type (2020-2031)
5 Contraceptive Drug Eluting Devices Market by Application
5.1 Contraceptive Drug Eluting Devices Application Introduction
5.1.1 Subcutaneously
5.1.2 Uterus
5.2 Global Contraceptive Drug Eluting Devices Sales by Application
5.2.1 Global Contraceptive Drug Eluting Devices Sales by Application (2020 VS 2024 VS 2031)
5.2.2 Global Contraceptive Drug Eluting Devices Sales by Application (2020-2031)
5.2.3 Global Contraceptive Drug Eluting Devices Sales Market Share by Application (2020-2031)
5.3 Global Contraceptive Drug Eluting Devices Revenue by Application
5.3.1 Global Contraceptive Drug Eluting Devices Revenue by Application (2020 VS 2024 VS 2031)
5.3.2 Global Contraceptive Drug Eluting Devices Revenue by Application (2020-2031)
5.3.3 Global Contraceptive Drug Eluting Devices Revenue Market Share by Application (2020-2031)
6 Global Contraceptive Drug Eluting Devices Sales by Region
6.1 Global Contraceptive Drug Eluting Devices Sales by Region: 2020 VS 2024 VS 2031
6.2 Global Contraceptive Drug Eluting Devices Sales by Region (2020-2031)
6.2.1 Global Contraceptive Drug Eluting Devices Sales by Region (2020-2025)
6.2.2 Global Contraceptive Drug Eluting Devices Sales Forecasted by Region (2025-2030)
6.3 North America
6.3.1 North America Contraceptive Drug Eluting Devices Sales Growth Rate by Country: 2020 VS 2024 VS 2031
6.3.2 North America Contraceptive Drug Eluting Devices Sales by Country (2020-2031)
6.3.3 U.S.
6.3.4 Canada
6.3.5 Mexico
6.4 Europe
6.4.1 Europe Contraceptive Drug Eluting Devices Sales Growth Rate by Country: 2020 VS 2024 VS 2031
6.4.2 Europe Contraceptive Drug Eluting Devices Sales by Country (2020-2031)
6.4.3 Germany
6.4.4 France
6.4.5 U.K.
6.4.6 Italy
6.4.7 Netherlands
6.5 Asia Pacific
6.5.1 Asia Pacific Contraceptive Drug Eluting Devices Sales Growth Rate by Country: 2020 VS 2024 VS 2031
6.5.2 Asia Pacific Contraceptive Drug Eluting Devices Sales by Country (2020-2031)
6.5.3 China
6.5.4 Japan
6.5.5 South Korea
6.5.6 Southeast Asia
6.5.7 India
6.5.8 Australia
6.6 South America, Middle East and Africa
6.6.1 South America, Middle East and Africa Contraceptive Drug Eluting Devices Sales Growth Rate by Country: 2020 VS 2024 VS 2031
6.6.2 South America, Middle East and Africa Contraceptive Drug Eluting Devices Sales by Country (2020-2031)
6.6.3 Brazil
6.6.4 South Africa
6.6.5 Saudi Arabia
6.6.6 Turkey
6.6.6 Argentina
6.6.6 UAE
6.6.6 Egypt
6.6.6 Chile
7 Global Contraceptive Drug Eluting Devices Revenue by Region
7.1 Global Contraceptive Drug Eluting Devices Revenue by Region
7.1.1 Global Contraceptive Drug Eluting Devices Revenue by Region: 2020 VS 2024 VS 2031
7.1.2 Global Contraceptive Drug Eluting Devices Revenue by Region (2020-2025)
7.1.3 Global Contraceptive Drug Eluting Devices Revenue by Region (2026-2031)
7.1.4 Global Contraceptive Drug Eluting Devices Revenue Market Share by Region (2020-2031)
7.2 North America
7.2.1 North America Contraceptive Drug Eluting Devices Revenue (2020-2031)
7.2.2 North America Contraceptive Drug Eluting Devices Revenue Share by Country: 2020 VS 2024 VS 2031
7.3 Europe
7.3.1 Europe Contraceptive Drug Eluting Devices Revenue (2020-2031)
7.3.2 Europe Contraceptive Drug Eluting Devices Revenue Share by Country: 2020 VS 2024 VS 2031
7.4 Asia-Pacific
7.4.1 Asia-Pacific Contraceptive Drug Eluting Devices Revenue (2020-2031)
7.4.2 Asia-Pacific Contraceptive Drug Eluting Devices Revenue Share by Country: 2020 VS 2024 VS 2031
7.5 South America, Middle East and Africa
7.5.1 South America, Middle East and Africa Contraceptive Drug Eluting Devices Revenue (2020-2031)
7.5.2 South America, Middle East and Africa Contraceptive Drug Eluting Devices Revenue Share by Country: 2020 VS 2024 VS 2031
8 Company Profiles
8.1 CooperSurgical
8.1.1 CooperSurgical Comapny Information
8.1.2 CooperSurgical Business Overview
8.1.3 CooperSurgical Contraceptive Drug Eluting Devices Sales, Price, Revenue and Gross Margin (2020-2025)
8.1.4 CooperSurgical Contraceptive Drug Eluting Devices Product Portfolio
8.1.5 CooperSurgical Recent Developments
8.2 Egemen International
8.2.1 Egemen International Comapny Information
8.2.2 Egemen International Business Overview
8.2.3 Egemen International Contraceptive Drug Eluting Devices Sales, Price, Revenue and Gross Margin (2020-2025)
8.2.4 Egemen International Contraceptive Drug Eluting Devices Product Portfolio
8.2.5 Egemen International Recent Developments
8.3 ERENLER MEDIKAL
8.3.1 ERENLER MEDIKAL Comapny Information
8.3.2 ERENLER MEDIKAL Business Overview
8.3.3 ERENLER MEDIKAL Contraceptive Drug Eluting Devices Sales, Price, Revenue and Gross Margin (2020-2025)
8.3.4 ERENLER MEDIKAL Contraceptive Drug Eluting Devices Product Portfolio
8.3.5 ERENLER MEDIKAL Recent Developments
8.4 Gyneas
8.4.1 Gyneas Comapny Information
8.4.2 Gyneas Business Overview
8.4.3 Gyneas Contraceptive Drug Eluting Devices Sales, Price, Revenue and Gross Margin (2020-2025)
8.4.4 Gyneas Contraceptive Drug Eluting Devices Product Portfolio
8.4.5 Gyneas Recent Developments
8.5 Laboratoire CCD
8.5.1 Laboratoire CCD Comapny Information
8.5.2 Laboratoire CCD Business Overview
8.5.3 Laboratoire CCD Contraceptive Drug Eluting Devices Sales, Price, Revenue and Gross Margin (2020-2025)
8.5.4 Laboratoire CCD Contraceptive Drug Eluting Devices Product Portfolio
8.5.5 Laboratoire CCD Recent Developments
8.6 Medical Engineering Corporation
8.6.1 Medical Engineering Corporation Comapny Information
8.6.2 Medical Engineering Corporation Business Overview
8.6.3 Medical Engineering Corporation Contraceptive Drug Eluting Devices Sales, Price, Revenue and Gross Margin (2020-2025)
8.6.4 Medical Engineering Corporation Contraceptive Drug Eluting Devices Product Portfolio
8.6.5 Medical Engineering Corporation Recent Developments
8.7 Melbea
8.7.1 Melbea Comapny Information
8.7.2 Melbea Business Overview
8.7.3 Melbea Contraceptive Drug Eluting Devices Sales, Price, Revenue and Gross Margin (2020-2025)
8.7.4 Melbea Contraceptive Drug Eluting Devices Product Portfolio
8.7.5 Melbea Recent Developments
8.8 Meril Life Sciences
8.8.1 Meril Life Sciences Comapny Information
8.8.2 Meril Life Sciences Business Overview
8.8.3 Meril Life Sciences Contraceptive Drug Eluting Devices Sales, Price, Revenue and Gross Margin (2020-2025)
8.8.4 Meril Life Sciences Contraceptive Drug Eluting Devices Product Portfolio
8.8.5 Meril Life Sciences Recent Developments
8.9 Mona Lisa
8.9.1 Mona Lisa Comapny Information
8.9.2 Mona Lisa Business Overview
8.9.3 Mona Lisa Contraceptive Drug Eluting Devices Sales, Price, Revenue and Gross Margin (2020-2025)
8.9.4 Mona Lisa Contraceptive Drug Eluting Devices Product Portfolio
8.9.5 Mona Lisa Recent Developments
8.10 Pregna
8.10.1 Pregna Comapny Information
8.10.2 Pregna Business Overview
8.10.3 Pregna Contraceptive Drug Eluting Devices Sales, Price, Revenue and Gross Margin (2020-2025)
8.10.4 Pregna Contraceptive Drug Eluting Devices Product Portfolio
8.10.5 Pregna Recent Developments
8.11 Pregna International
8.11.1 Pregna International Comapny Information
8.11.2 Pregna International Business Overview
8.11.3 Pregna International Contraceptive Drug Eluting Devices Sales, Price, Revenue and Gross Margin (2020-2025)
8.11.4 Pregna International Contraceptive Drug Eluting Devices Product Portfolio
8.11.5 Pregna International Recent Developments
8.12 Prosan International
8.12.1 Prosan International Comapny Information
8.12.2 Prosan International Business Overview
8.12.3 Prosan International Contraceptive Drug Eluting Devices Sales, Price, Revenue and Gross Margin (2020-2025)
8.12.4 Prosan International Contraceptive Drug Eluting Devices Product Portfolio
8.12.5 Prosan International Recent Developments
8.13 Rongbo Medical
8.13.1 Rongbo Medical Comapny Information
8.13.2 Rongbo Medical Business Overview
8.13.3 Rongbo Medical Contraceptive Drug Eluting Devices Sales, Price, Revenue and Gross Margin (2020-2025)
8.13.4 Rongbo Medical Contraceptive Drug Eluting Devices Product Portfolio
8.13.5 Rongbo Medical Recent Developments
8.14 SMB Corporation of India
8.14.1 SMB Corporation of India Comapny Information
8.14.2 SMB Corporation of India Business Overview
8.14.3 SMB Corporation of India Contraceptive Drug Eluting Devices Sales, Price, Revenue and Gross Margin (2020-2025)
8.14.4 SMB Corporation of India Contraceptive Drug Eluting Devices Product Portfolio
8.14.5 SMB Corporation of India Recent Developments
8.15 AbbVie
8.15.1 AbbVie Comapny Information
8.15.2 AbbVie Business Overview
8.15.3 AbbVie Contraceptive Drug Eluting Devices Sales, Price, Revenue and Gross Margin (2020-2025)
8.15.4 AbbVie Contraceptive Drug Eluting Devices Product Portfolio
8.15.5 AbbVie Recent Developments
8.16 Bayer
8.16.1 Bayer Comapny Information
8.16.2 Bayer Business Overview
8.16.3 Bayer Contraceptive Drug Eluting Devices Sales, Price, Revenue and Gross Margin (2020-2025)
8.16.4 Bayer Contraceptive Drug Eluting Devices Product Portfolio
8.16.5 Bayer Recent Developments
9 Value Chain and Sales Channels Analysis
9.1 Contraceptive Drug Eluting Devices Value Chain Analysis
9.1.1 Contraceptive Drug Eluting Devices Key Raw Materials
9.1.2 Raw Materials Key Suppliers
9.1.3 Manufacturing Cost Structure
9.1.4 Contraceptive Drug Eluting Devices Production Mode & Process
9.2 Contraceptive Drug Eluting Devices Sales Channels Analysis
9.2.1 Direct Comparison with Distribution Share
9.2.2 Contraceptive Drug Eluting Devices Distributors
9.2.3 Contraceptive Drug Eluting Devices Customers
10 Concluding Insights
11 Appendix
11.1 Reasons for Doing This Study
11.2 Research Methodology
11.3 Research Process
11.4 Authors List of This Report
11.5 Data Source
11.5.1 Secondary Sources
11.5.2 Primary Sources
11.6 Disclaimer

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings